DexCom, Inc. DXCM

86.62 (0.85) (0.97%) as of 25 Sep

Follow DXCM

S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years,

Insider Buys alert about insiders buying in the last 12 month

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE	38.49%	35.62%	34.50%	30.63%	+8 more TTM periods Free account
ROA	14.51%	13.90%	13.04%	10.40%
ROIC	37.13%	36.21%	28.66%	75.49%
Return on Tangible Assets	30.24%	25.37%	24.24%	21.48%
Average Days of Receivables	92.38	82.47	95.21	89.68
Free Cash Flow per Share	3.68	3.71	2.76	2.72
Free Cash Flow	1,405.00	1,429.40	1,077.20	1,061.90
Capital Expenditures	(343.70)	(353.10)	(363.50)	(386.20)
Piotroski F-Score	7.00	7.00	6.00	5.00
Other line items
Cash ROIC	30.09%	26.95%	24.07%	19.87%
Accounts Receivable Turnover	3.81	4.29	4.20	4.28
Accounts Payable Turnover	0.90	0.99	1.05	1.05
Inventory Turnover	2.88	3.01	3.18	3.11
Average Days of Payables	428.95	408.14	381.46	381.07
Days of Inventory on Hand	142.18	136.50	123.45	119.13
Tax Rate	(0.22)	(0.23)	(0.23)	(0.25)
Research and Development Expense of Revenue	12.15%	12.44%	12.85%	13.07%
Selling, General and Administrative Expense of Revenue	27.39%	27.62%	27.69%	28.72%
Share Based Compensation of Revenue	3.27%	3.50%	3.42%	3.72%
Interest Coverage	0.00	0.00	0.00	0.00
Operating CF/Net income	1.75	1.92	1.72	2.01
Depreciation/Fixed assets	0.17	0.17	0.16	0.17
Capex/Depreciation	(1.30)	(1.36)	(1.44)	(1.58)
Revenue per Share	13.00	12.51	11.95	11.55
Operating CF per Share	4.58	4.63	3.69	3.70
Capex per Share	(0.90)	(0.92)	(0.93)	(0.99)
Capex to Sales	0.07	0.07	0.08	0.09
Net Profit Margin	20.12%	19.31%	17.94%	15.96%

Columns are period end dates

Powerpack